On day 7, CD56+ and CD3+ NK cells were isolated from PBMCs that were either activated with IL-12, IL-15, and IL-18 or control conditions and the cytotoxicity of the four groups of cells against HCC was verified when the quantity of cells was equal. The gene discussed is NCAM1; the disease is hepatocellular carcinoma.